Intravesical instillation
Showing 1 - 25 of 597
High-risk Non-muscle Invasive Bladder Cancer Trial (SHR-2005)
Not yet recruiting
- High-risk Non-muscle Invasive Bladder Cancer
- (no location specified)
Oct 25, 2023
Bacillus Calmette Guerin With Use of Different Types of Urinary
Completed
- Non-muscle-invasive Bladder Cancer
-
Marathon, Attica, GreeceThemistoklis Bellos
Jan 10, 2023
Non-muscle Invasive Bladder Cancer Trial (TARA-002)
Not yet recruiting
- Non-muscle Invasive Bladder Cancer
- TARA-002
- (no location specified)
Jul 14, 2023
Non-muscle Invasive Bladder Cancer Trial in Aarhus (Urodynamic examination)
Recruiting
- Non-muscle Invasive Bladder Cancer
- Urodynamic examination
-
Aarhus, DenmarkAarhus University Hospital
Aug 5, 2022
Non-muscle Invasive Bladder Cancer Trial (TARA-002)
Not yet recruiting
- Non-muscle Invasive Bladder Cancer
- TARA-002
- (no location specified)
Aug 24, 2022
Upper Urinary Tract Urothelial Carcinoma, Bladder Cancer Trial in Vienna (Intravesical Solution)
Not yet recruiting
- Upper Urinary Tract Urothelial Carcinoma
- Bladder Cancer
- Intravesical Solution
-
Vienna, Austria
- +1 more
Mar 31, 2023
Bladder Cancer Trial in Goyang (intravesical mitomycin-C 40mg/20ml instillation)
Completed
- Bladder Cancer
- intravesical mitomycin-C 40mg/20ml instillation
-
Goyang, Korea, Republic ofNational Cancer Center
Jan 30, 2023
Urothelial Carcinoma Trial in Gainesville (Mitomycin c)
Active, not recruiting
- Urothelial Carcinoma
- Mitomycin c
-
Gainesville, FloridaUniversity of Florida
Dec 6, 2022
Non-muscle Invasive Bladder Cancer Trial in Hanover, Mount Laurel, Rochester (TARA-002)
Recruiting
- Non-muscle Invasive Bladder Cancer
- TARA-002
-
Los Angeles, California
- +11 more
Jan 31, 2023
Bladder Cancer Trial in Jinan (Pseudomonas aeruginosa)
Recruiting
- Bladder Cancer
- Pseudomonas aeruginosa
-
Jinan, Shandong, ChinaQilu hospital
Jul 26, 2023
Bladder Cancer, Epirubicin Adverse Reaction, Superficial Bladder Cancer Trial in Ankara (Intravesical Solution)
Recruiting
- Bladder Cancer
- +3 more
- Intravesical Solution
-
Ankara, Altindag, TurkeyAnkara Training and Research Hospital
Jul 4, 2022
Non-muscle Invasive Bladder Cancer Trial in Shanghai (APL-1202, Epirubicin Hydrochloride)
Recruiting
- Non-muscle Invasive Bladder Cancer
- APL-1202
- Epirubicin Hydrochloride
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Feb 21, 2022
Bladder Cancer Trial in Larissa (Gemcitabine Hydrochloride combined with continuous saline irrigation, Epirubicin Hydrochloride
Recruiting
- Bladder Cancer
- Gemcitabine Hydrochloride combined with continuous saline irrigation
- Epirubicin Hydrochloride combined with continuous saline irrigation
-
Larissa, Larissa/Thessaly, GreeceUrology Department, University of Thessaly, University Hospital
Jan 25, 2022
Bladder Cancer, Urothelial Carcinoma, Urinary Bladder Tumor Trial in United States (NanoDoce (direct injection), NanoDoce
Completed
- Bladder Cancer
- +8 more
- NanoDoce (direct injection)
- +3 more
-
Phoenix, Arizona
- +4 more
Nov 29, 2021
Urinary Tract Infections, Urinary Tract Infection (UTI) Trial in Basel (intravesical instillation with HA-CS, intravesical
Recruiting
- Urinary Tract Infections
- Urinary Tract Infection (UTI)
- intravesical instillation with HA-CS
- intravesical instillation of sterile purified water
-
Basel, Switzerland
- +1 more
Nov 1, 2021
Urothelial Carcinoma Trial in Goyang, Seoul (Intravesical 2000mg/52.6ml gemcitabine instillation, Normal saline)
Recruiting
- Urothelial Carcinoma
- Intravesical 2000mg/52.6ml gemcitabine instillation
- Normal saline
-
Goyang, Korea, Republic of
- +4 more
Apr 6, 2022
Urothelial Carcinoma Ureter, Urothelial Cancer of Renal Pelvis Trial (Mitomycin C)
Not yet recruiting
- Urothelial Carcinoma Ureter
- Urothelial Cancer of Renal Pelvis
- Mitomycin C
- (no location specified)
Jul 31, 2023
Non-muscle-invasive Bladder Cancer Trial in Beijing (OH2 injection)
Recruiting
- Non-muscle-invasive Bladder Cancer
- OH2 injection
-
Beijing, Beijing, ChinaNational Cancer Center/Cancer Hospital, Chinese Academy of Medic
Jul 12, 2022
Voiding Disorders Trial in Mansoura (Mirabegron, Propevirine, Solifenacin)
Recruiting
- Voiding Disorders
- Mirabegron, Propevirine, Solifenacin
-
Mansoura, EgyptUrology and Nephrology Center, Mansoura University
Aug 3, 2022
Upper Urinary Tract Carcinoma Trial
Not yet recruiting
- Upper Urinary Tract Carcinoma
- (no location specified)
Feb 7, 2023
Postoperative Urinary Tract Infection, Pelvic Organ Prolapse, Stress Urinary Incontinence Trial in La Jolla, San Diego
Completed
- Postoperative Urinary Tract Infection
- +2 more
- gentamicin sulfate
- Catheter clamping only
-
La Jolla, California
- +1 more
Oct 17, 2022
Recurrent Urinary Tract Infections Trial in Tulsa (Intravesical Heparin, Placebo)
Recruiting
- Recurrent Urinary Tract Infections
- Intravesical Heparin
- Placebo
-
Tulsa, OklahomaUniversity of Oklahoma-Tulsa OB/GYN Dept and OU-Physicians
Oct 31, 2022
Interstitial Cystitis, Chronic Interstitial Cystitis, Bladder Pain Syndrome Trial in Winston-Salem (Pulsed Electromagnetic Field
Not yet recruiting
- Interstitial Cystitis
- +2 more
- Pulsed Electromagnetic Field (PEMF) Device
- Sham Pulsed Electromagnetic Feild (PEMF) Device
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
Aug 22, 2023
Interstitial Cystitis, Bladder Pain Syndrome Trial in United States (SI-722, Placebo)
Completed
- Interstitial Cystitis
- Bladder Pain Syndrome
- SI-722
- Placebo
-
Los Angeles, California
- +4 more
Dec 15, 2021